NISA INVESTMENT ADVISORS, LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q4 2022$24
-99.9%
3,800
-1.9%
0.00%
Q3 2022$31,000
+29.2%
3,874
+1.9%
0.00%
Q2 2022$24,000
+33.3%
3,8000.0%0.00%
Q1 2022$18,000
+260.0%
3,800
+838.3%
0.00%
Q3 2021$5,000
-44.4%
4050.0%0.00%
Q2 2021$9,000
-86.6%
405
-83.2%
0.00%
Q1 2021$67,000
+6.3%
2,4050.0%0.00%
Q4 2020$63,000
+600.0%
2,405
+843.1%
0.00%
Q3 2020$9,000
-30.8%
2550.0%0.00%
Q2 2020$13,000
+116.7%
255
+27.5%
0.00%
Q1 2020$6,000
-50.0%
2000.0%0.00%
Q4 2019$12,000
+71.4%
2000.0%0.00%
Q3 2019$7,000
+16.7%
200
+53.8%
0.00%
Q2 2019$6,000
+20.0%
1300.0%0.00%
Q1 2019$5,000
-16.7%
1300.0%0.00%
Q4 2018$6,0000.0%1300.0%0.00%
Q3 2018$6,000
-40.0%
130
-50.0%
0.00%
Q2 2018$10,000
-9.1%
260
+73.3%
0.00%
Q1 2018$11,000
-31.2%
150
-40.0%
0.00%
Q4 2017$16,0002500.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2020
NameSharesValueWeighting ↓
Meditor Group Ltd 2,679,835$69,675,00019.39%
Endurant Capital Management LP 207,293$5,390,0001.94%
Bellevue Group AG 5,138,451$133,599,0001.53%
Rhenman & Partners Asset Management AB 592,225$15,398,0001.26%
PLATINUM INVESTMENT MANAGEMENT LTD 1,562,869$40,635,0000.93%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 31,434$817,0000.62%
WASATCH ADVISORS LP 3,998,010$103,949,0000.51%
HAMILTON LANE ADVISORS LLC 46,181$1,201,0000.45%
Boxer Capital, LLC 500,000$13,000,0000.42%
DCF Advisers, LLC 38,500$1,001,0000.41%
View complete list of ESPERION THERAPEUTICS INC NE shareholders